ES2057065T3 - Composicion mejoradora de la dismnesia. - Google Patents

Composicion mejoradora de la dismnesia.

Info

Publication number
ES2057065T3
ES2057065T3 ES89120897T ES89120897T ES2057065T3 ES 2057065 T3 ES2057065 T3 ES 2057065T3 ES 89120897 T ES89120897 T ES 89120897T ES 89120897 T ES89120897 T ES 89120897T ES 2057065 T3 ES2057065 T3 ES 2057065T3
Authority
ES
Spain
Prior art keywords
dysmnesia
improving composition
carbons
hydrogen
dysnesia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89120897T
Other languages
English (en)
Inventor
Mitsuo Ohashi
Fukuraro Taga
Takashi Hirayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2057065T3 publication Critical patent/ES2057065T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

UNA COMPOSICION MEJORADA PARA DISNESIA, COMPRENDIENDO COMO UN INGREDIENTE ACTIVO AL MENOS UN DERIVADO DE PIRAZOLO[1,5-A]PIRIDINA REPRESENTADO POR LA FORMULA GENERAL: EN DONDE R1 Y R2 SON INDEPENDIENTEMENTE HIDROGENO O UN ALQUILO INFERIOR DE 1 A 4 CARBONOS, R3 ES HIDROGENO O ALQUILO INFERIOR DE 1 A 3 CARBONOS O UN ALCOXI INFERIOR DE 1 A 3 CARBONOS.
ES89120897T 1988-11-11 1989-11-10 Composicion mejoradora de la dismnesia. Expired - Lifetime ES2057065T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63285217A JPH085790B2 (ja) 1988-11-11 1988-11-11 記憶障害改善薬

Publications (1)

Publication Number Publication Date
ES2057065T3 true ES2057065T3 (es) 1994-10-16

Family

ID=17688622

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89120897T Expired - Lifetime ES2057065T3 (es) 1988-11-11 1989-11-10 Composicion mejoradora de la dismnesia.

Country Status (7)

Country Link
US (1) US4990516A (es)
EP (1) EP0368343B1 (es)
JP (1) JPH085790B2 (es)
KR (1) KR960006066B1 (es)
AU (1) AU614201B2 (es)
DE (1) DE68907392T2 (es)
ES (1) ES2057065T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280032A (en) * 1989-02-14 1994-01-18 Toyama Chemical Co., Ltd. 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
JP2873898B2 (ja) * 1992-04-13 1999-03-24 富山化学工業株式会社 ベンゾ［ｂ］チオフェン−５−イル誘導体もしくはその光学活性体またはそれらの塩並びにそれらの製造法
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
AU2002251546B2 (en) * 2001-04-27 2007-01-18 Eisai R & D Management Co., Ltd. Pyrazolo[1,5-A]pyridines and medicines containing the same
DK1555265T3 (da) * 2002-10-22 2009-06-22 Eisai R&D Man Co Ltd 7-phenylpyrazolopyridin-forbindelser
US7176216B2 (en) * 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
EP1570847B1 (en) * 2002-12-03 2012-04-25 Kyorin Pharmaceutical Co., Ltd. Phosphodiesterase 10a inhibitors for use in the treatment of parkinson's disease, huntington's disease and schizophrenia
KR101601994B1 (ko) 2008-04-15 2016-03-17 에자이 알앤드디 매니지먼트 가부시키가이샤 3-페닐피라졸로[5,1-ｂ]티아졸 화합물
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
EP2487177A1 (en) * 2009-10-08 2012-08-15 Eisai R&D Management Co., Ltd. Pyrazoloxazole compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5229318B2 (es) * 1972-03-30 1977-08-01
US4647566A (en) * 1984-07-09 1987-03-03 Ciba-Geigy Corporation Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives in treating anxiety
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
JPH01153634A (ja) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 吸入剤

Also Published As

Publication number Publication date
EP0368343A3 (en) 1990-12-27
JPH085790B2 (ja) 1996-01-24
DE68907392D1 (de) 1993-08-05
AU4446889A (en) 1990-05-17
US4990516A (en) 1991-02-05
EP0368343B1 (en) 1993-06-30
EP0368343A2 (en) 1990-05-16
KR900007415A (ko) 1990-06-01
KR960006066B1 (ko) 1996-05-08
DE68907392T2 (de) 1993-10-14
JPH02131424A (ja) 1990-05-21
AU614201B2 (en) 1991-08-22

Similar Documents

Publication Publication Date Title
EP0257102A4 (en) Agents for treating neurophathy
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
ES8801649A1 (es) Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isoxazoles y furanos
NO154089C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
ES2057065T3 (es) Composicion mejoradora de la dismnesia.
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
EP0194161A3 (en) Cyclopentaûd¨pyrimidine derivatives, their preparation and use
DE69530303D1 (de) Neue verwendung von prostaglandinen
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
IE872588L (en) Compounds
ATE99295T1 (de) Benzimidazol-derivate mit pharmakologischer aktivitaet.
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
PE25998A1 (es) DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS
MY101261A (en) New 4-pyridone derivatives, method of their production and their pharmaceutical compositions.
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
ES8605538A1 (es) Procedimiento para la preparacion de nonapeptidos y dodecapeptidos
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
MX170732B (es) Composicion de derivados de succinimida y su uso
CO4970779A1 (es) Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis
IT1191845B (it) Alchiloli derivati farmacologicamente attivi
ES2019871B3 (es) 1,2,3,4,4a,9b-hexahidro-4a-aminoalquildibenzofuranos, un proceso para su preparacion y su uso como medicamentos.
EP0397613A3 (en) Pharmacologically active aminoimidazopyridines
IE893211L (en) Benzoxazepinone Process
MY104777A (en) Benzoxazine dyes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 368343

Country of ref document: ES